Loss of NAT10 alleviates maternal high‐fat diet‐induced hepatic steatosis in male offspring of mice
Obesity · 2024
DOI: 10.1002/oby.24041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, 2024. Verfasst von Qian-Ren Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Fatty Liver, Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Chi…. Hauptthemen laut MEDLINE: Diet, High-Fat, Mice, Knockout, Lipid Metabolism, Liver. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Foundation of State Key Laboratory of Oncogenes and Related Genes, National Natural Science Foundation of China, Shanghai Municipal Health Commission.
Abstract (Originalsprache)
Objective
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is becoming an escalating health problem in pediatric populations. This study aimed to investigate the role of N‐acetyltransferase 10 (NAT10) in maternal high‐fat diet (HFD)‐induced MASLD in offspring at early life.
Methods
We generated male hepatocyte‐specific NAT10 knockout ( Nat10 HKO ) mice and mated them with female Nat10 fl/fl mice under chow or HFD feeding. Body weight, liver histopathology, and expression of lipid metabolism–associated genes ( Srebp1c , Fasn , Pparα , Cd36 , Fatp2 , Mttp , and Apob ) were assessed in male offspring at weaning. Lipid uptake assays were performed both in vivo and in vitro. The mRNA stability assessment and RNA immunoprecipitation were performed to determine NAT10‐regulated target genes.
Results
NAT10 deletion in hepatocytes of male offspring alleviated perinatal lipid accumulation induced by maternal HFD, decreasing expression levels of Srebp1c , Fasn , Cd36 , Fatp2 , Mttp , and Apob while enhancing Pparα expression. Furthermore, Nat10 HKO male mice exhibited reduced lipid uptake. In vitro, NAT10 promoted lipid uptake by enhancing the mRNA stability of CD36 and FATP2. RNA immunoprecipitation assays exhibited direct interactions between NAT10 and CD36/FATP2 mRNA.
Conclusions
NAT10 deletion in offspring hepatocytes ameliorates maternal HFD‐induced hepatic steatosis through decreasing mRNA stability of CD36 and FATP2, highlighting NAT10 as a potential therapeutic target for pediatric MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Fatty Liver, Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Key Lab of Pediatric Gastroenterology and Nutrition, Shanghai, China.
ORCID-Profile: Qian-Ren Zhang, Jian-Gao Fan
Förderung
- Foundation of State Key Laboratory of Oncogenes and Related Genes
- National Natural Science Foundation of China
- Shanghai Municipal Health Commission
Zitieren
APA
Zhang, Q. R., Zhang, J. B., Shen, F., Xue, R., Yang, R. X., Ren, T. Y., & Fan, J. G. (2024). Loss of NAT10 alleviates maternal high‐fat diet‐induced hepatic steatosis in male offspring of mice. Obesity. https://doi.org/10.1002/oby.24041
Vancouver
Zhang QR, Zhang JB, Shen F, Xue R, Yang RX, Ren TY, et al. Loss of NAT10 alleviates maternal high‐fat diet‐induced hepatic steatosis in male offspring of mice. Obesity. 2024. doi:10.1002/oby.24041
BibTeX
@article{Zhang2024,
author = {Zhang, Qian-Ren and Zhang, Jian-Bin and Shen, Feng and Xue, Rui and Yang, Rui-Xu and Ren, Tian-Yi and Fan, Jian-Gao},
title = {Loss of NAT10 alleviates maternal high‐fat diet‐induced hepatic steatosis in male offspring of mice},
journal = {Obesity},
year = {2024},
doi = {10.1002/oby.24041}
}
EUVIMED